주요메뉴 바로가기 본문 바로가기

주메뉴

IBS Conferences

The astrocytic urea cycle in the brain controls memory impairment in Alzheimer’s Disease

- New results reveal the urea cycle in astrocytes as the link between amyloid-beta accumulation and memory loss, providing enzyme ODC1 as a new therapeutic target to treat Alzheimer’s Disease -

The number of elderly suffering from Alzheimer’s Disease has been rapidly rising over the past decades. For a long time, scientists believed that misfolded aggregates of amyloid-beta protein accumulate and form plaques in the brain, leading to memory loss and neuronal death. However, the recent failures of the clinical trials indicate the pressing need to understand the missing link between amyloid-beta protein plaques and the disease’s symptoms, a phenomenon that has been studied for over decades.

Researchers led by Director C. Justin LEE from the Center for Cognition and Sociality within the Institute for Basic Science (IBS), South Korea, have delved extensively into this topic. Recently in 2020, the group published in the journal Nature Neuroscience that the star-shaped cells in the brain, called astrocytes, are greatly involved in Alzheimer’s Disease and its progression. Driven by this discovery, the group sought to further explore the molecular connection underlying the astrocytic response.

After studying basic cellular pathways and how they change in the star-shaped astrocytes of the brain, the IBS team now has found the missing link: the conversion of amyloid-beta to urea in the brain.

The urea cycle is widely studied and understood as a major metabolic pathway in the liver and kidneys, as a part of our digestive and excretory processes. In the liver, the urea cycle converts ammonia, a toxic product from protein digestion, into urea, which is easily excreted by our kidneys as urine. Surprisingly, previous studies have reported increased urea in the brain of Alzheimer’s Disease patients, which led the IBS team to wonder if the urea cycle played any role in the pathology of the disease. To their surprise, they found that the urea cycle is ‘switched on’ in the astrocytes of the Alzheimer’s Disease brain, in order to clean up the toxic amyloid-beta aggregates and remove them in the form of urea.


Figure 1. Next-Generation RNA Sequencing and metabolite analysis reveals that the non-cyclic urea metabolism of astrocytes turns to a cyclic state in reactive AD-like conditions.
Figure 1. Next-Generation RNA Sequencing and metabolite analysis reveals that the non-cyclic urea metabolism of astrocytes turns to a cyclic state in reactive AD-like conditions.


However, this isn’t as beneficial as it sounds. The group found that the switching on of the urea cycle causes the production of ornithine, another metabolite that accumulates in the cell and needs to be cleaned up. The hardworking astrocytes produce the enzyme ornithine decarboxylase 1 (ODC1) in this condition to deal with the accumulated ornithine and convert it to putrescine. This consequently increases the levels of neurotransmitter γ-aminobutyric acid (GABA), as well as toxic byproducts like hydrogen peroxide (H2O2) and ammonia in the brain.

This ammonia further feeds back into the urea cycle and continues this process, causing more and more accumulation of toxic byproducts. High levels of GABA released by these astrocytes play an inhibitory action on neuronal transmission, contributing to the tell-tale loss of memory in Alzheimer’s Disease.

In the above-mentioned 2020 study by the group, hydrogen peroxide was found to be the primary factor causing the severe reactivity of diseased astrocytes, causing neuronal cell death. Now, the new findings from this study precisely explain how the increased GABA, H2O2, and ammonia contribute to and exacerbate the loss of memory and neuronal cell death associated with Alzheimer’s Disease.

The first author JU Yeon Ha stated, “For years, scientists have been debating about the beneficial and detrimental role of reactive astrocytes, and with the findings of this study, our group is able to clearly demarcate the beneficial urea cycle and the detrimental conversion of ornithine to putrescine and GABA, thereby providing evidence of the dual nature of astrocytes in Alzheimer’s Disease brain.”

The group experimented further to exploit this new knowledge. They found that astrocyte-specific gene silencing of the enzyme Ornithine Decarboxylase 1 in a transgenic Alzheimer’s Disease mouse model was able to stop the excessive GABA production and neuronal inhibition in the hippocampus of the mouse brain. These animals performed better in memory-related behavioral tasks, almost completely recovering from the AD-associated loss of memory after ODC1 knockdown. Additionally, the number of amyloid-beta plaques was significantly fewer in ODC1-gene silenced mouse brains, indicating that the urea cycle was working more efficiently to clear the accumulated protein without causing the accumulation of harmful byproducts such as H2O2, GABA and ammonia.


Figure 2. PyrPeg, a compound that specifically stains accumulated amyloid-beta plaques, shows that astrocyte-specific knockdown of ODC1 reduces the number of amyloid plaques in the AD mouse model brain (left). Neuronal inhibition is recovered (top right) by ODC1 silencing, as can be seen by the number of spikes produced on current injection in the hippocampus. Recovery of memory loss can be seen in the improved performance of the ODC1-silenced AD mouse in the Passive Avoidance Test (right bottom).
Figure 2. PyrPeg, a compound that specifically stains accumulated amyloid-beta plaques, shows that astrocyte-specific knockdown of ODC1 reduces the number of amyloid plaques in the AD mouse model brain (left). Neuronal inhibition is recovered (top right) by ODC1 silencing, as can be seen by the number of spikes produced on current injection in the hippocampus. Recovery of memory loss can be seen in the improved performance of the ODC1-silenced AD mouse in the Passive Avoidance Test (right bottom).


Director C. Justin LEE, the corresponding author of the study remarked, “With the results from this study, we were able to finally delineate the pathway linking amyloid-beta plaques to astrocytic reactivity, uncovering the presence of a functional urea cycle in reactive astrocytes for the first time. We also found increased levels of enzyme ODC1 in human AD patients' brains, raising the possibility of translating the results from our mouse study to humans and indicating that ODC1 may be a novel and powerful therapeutic target against the disease, inhibition of which could clear amyloid-beta plaques as well as improve memory.”

This research was published in Cell Metabolism, a CellPress journal with a strong impact factor of 27.28. Due to the significance and novelty of the study, the lead author Dr. JU Yeonha was invited to present the findings at the journal’s symposium Metabolites in Signalling and Disease in Lisbon, Portugal in April.

Notes for editors

- Reference
Yeon Ha Ju, Mridula Bhalla, Seung Jae Hyeon, Ju Eun Oh, Seonguk Yoo, Uikyu Chae, Jae Kwon, Wuhyun Koh, Jiwoon Lim, Yongmin Mason Park, Junghee Lee, Il-Joo, Astrocytic urea cycle detoxifies Aβ-derived ammonia while impairing memory in Alzheimer’s disease, Cell Metabolism (2022)
Chun, H., Im, H., Kang, Y. J., Kim, Y., Shin, J. H., Won, W., ... & Lee, C. J. Severe reactive astrocytes precipitate pathological hallmarks of Alzheimer’s disease via H2O2− production. Nature Neuroscience, 23(12), 1555-1566 (2020).


- Media Contact
For further information or to request media assistance, please contact Director C. Justin Lee at the Center for Cognition and Sociality, Institute for Basic Science (IBS) (cjl@ibs.re.kr) or William I. Suh at the IBS Communications Team (willisuh@ibs.re.kr).


- About the Institute for Basic Science (IBS)
IBS was founded in 2011 by the government of the Republic of Korea with the sole purpose of driving forward the development of basic science in South Korea. IBS has 34 research centers as of May 2022. There are eleven physics, three mathematics, seven chemistry, seven life science, one earth science, and five interdisciplinary research centers.

  • [Neuroscience] How the Astrocytic Urea Cycle in the Brain Controls Memory Impairment in Alzheimer’s Disease
  • [ScienceDaily] Astrocytic urea cycle in the brain controls memory impairment in Alzheimer's disease
  • [EurekAlert!] The astrocytic urea cycle in the brain controls memory impairment in Alzheimer’s disease
  • [FUNANCIAL NEWS] How the astrocytic urea cycle in the brain controls memory loss in Alzheimer’s disease Neuroscience News
  • [Bioengineer] The astrocytic urea cycle in the brain controls memory impairment in Alzheimer’s disease
  • [The Korea Herald] Researchers uncover new cause behind Alzheimer’s memory loss
  • Research

    Are you satisfied with the information on this page?

    Content Manager
    Public Relations Team : Yim Ji Yeob   042-878-8173
    Last Update 2023-11-28 14:20